Chemed Reports Q4 EPS of $0.98 vs. $1.05
Chemed Corporation (NYSE: CHE), which operates VITAS Healthcare Corporation reported financial results for its fourth quarter ended December 31, 2010.
- Revenue increased 10.9% to $336 million
- Net Income increased 25.8% to $22.6 million
- Adjusted Net Income increased 15.1% to $27.9 million
- EPS $0.98
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.